RJA
THQ

Raymond James & Associates’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Raymond James & Associates’s Portfolio THQ Stock Details THQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$15.2M Sell
686,667
-140,554
-17% -$3.01M 0.01% 977
2024
Q2 		$16.9M Buy
827,221
+29,946
+4% +$595K 0.01% 863
2024
Q1 		$16M Buy
797,275
+14,242
+2% +$274K 0.01% 881
2023
Q4 		$14.2M Buy
783,033
+15,867
+2% +$268K 0.01% 907
2023
Q3 		$13M Sell
767,166
-23,477
-3% -$436K 0.01% 886
2023
Q2 		$15.1M Sell
790,643
-85,676
-10% -$1.61M 0.01% 830
2023
Q1 		$16.4M Sell
876,319
-32,696
-4% -$626K 0.01% 767
2022
Q4 		$18M Buy
909,015
+10,597
+1% +$209K 0.02% 718
2022
Q3 		$16.3M Buy
898,418
+12,793
+1% +$256K 0.02% 709
2022
Q2 		$17.7M Sell
885,625
-16,137
-2% -$338K 0.02% 681
2022
Q1 		$20.1M Sell
901,762
-790
-0.1% -$17.7K 0.02% 703
2021
Q4 		$23.1M Buy
902,552
+23,006
+3% +$553K 0.02% 677
2021
Q3 		$19.9M Buy
879,546
+29,412
+3% +$709K 0.02% 707
2021
Q2 		$19.6M Sell
850,134
-23,109
-3% -$531K 0.02% 720
2021
Q1 		$19M Buy
873,243
+32,792
+4% +$687K 0.02% 694
2020
Q4 		$17.1M Buy
840,451
+11,289
+1% +$216K 0.02% 688
2020
Q3 		$15M Sell
829,162
-67,045
-7% -$1.22M 0.02% 666
2020
Q2 		$16M Buy
896,207
+9,273
+1% +$164K 0.02% 615
2020
Q1 		$13.6M Sell
886,934
-82,318
-8% -$1.45M 0.02% 609
2019
Q4 		$18.5M Sell
969,252
-6,047
-0.6% -$109K 0.02% 617
2019
Q3 		$17M Buy
975,299
+54,949
+6% +$963K 0.02% 611
2019
Q2 		$16.4M Sell
920,350
-3,035
-0.3% -$52.1K 0.02% 619
2019
Q1 		$16.3M Buy
923,385
+3,171
+0.3% +$55.3K 0.02% 595
2018
Q4 		$15.4M Buy
920,214
+97,120
+12% +$1.72M 0.03% 565
2018
Q3 		$15.4M Buy
823,094
+101,194
+14% +$1.83M 0.02% 638
2018
Q2 		$12.3M Buy
721,900
+36,805
+5% +$617K 0.02% 709
2018
Q1 		$11.3M Buy
685,095
+36,750
+6% +$642K 0.02% 712
2017
Q4 		$11.4M Sell
648,345
-87,239
-12% -$1.55M 0.02% 707
2017
Q3 		$13.7M Buy
735,584
+104,225
+17% +$1.91M 0.03% 590
2017
Q2 		$11.6M Buy
631,359
+76,232
+14% +$1.34M 0.03% 644
2017
Q1 		$9.66M Buy
555,127
+40,391
+8% +$689K 0.02% 689
2016
Q4 		$7.99M Buy
514,736
+72,472
+16% +$1.17M 0.02% 739
2016
Q3 		$7.73M Buy
442,264
+58,061
+15% +$1.01M 0.02% 727
2016
Q2 		$6.39M Buy
384,203
+53,086
+16% +$867K 0.02% 737
2016
Q1 		$5.27M Buy
331,117
+34,877
+12% +$539K 0.02% 792
2015
Q4 		$5.15M Buy
296,240
+32,878
+12% +$564K 0.02% 799
2015
Q3 		$4.29M Buy
263,362
+99,736
+61% +$1.91M 0.02% 821
2015
Q2 		$3.25M Buy
163,626
+5,682
+4% +$117K 0.01% 1049
2015
Q1 		$3.25M Buy
157,944
+51,121
+48% +$1.03M 0.01% 961
2014
Q4 		$2.14M Buy
106,823
+16,040
+18% +$311K 0.01% 1117
2014
Q3 		$1.71M Buy
+90,783
New +$1.81M 0.01% 1178

Other funds holding THQ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James & Associates's THQ Position: Q3 2024 in Review

Raymond James & Associates reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 17% in Q3 2024, selling an estimated $3.01M and leaving 686,667 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #977.

Raymond James & Associates first reported a position in THQ in Q3 2014 and has held it in 41 quarters since. The position peaked at $23.1M in Q4 2021. 103 funds tracked by Wall St. Rank hold THQ as of Q3 2024.

  • Raymond James & Associates held 686,667 shares of abrdn Healthcare Opportunities Fund worth $15.2M as of Q3 2024.
  • Raymond James & Associates sold 140,554 abrdn Healthcare Opportunities Fund shares in Q3 2024, an estimated $3.01M.
  • abrdn Healthcare Opportunities Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #977 holding.
  • Raymond James & Associates first reported a position in abrdn Healthcare Opportunities Fund in Q3 2014 and has held it in 41 quarters since.
  • Raymond James & Associates's abrdn Healthcare Opportunities Fund position peaked at $23.1M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.